Approval · Notice of Compliance 1877 · 1999
ALDARA: Notice of Compliance 1877
Issued January 25, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1877
- Date
- January 25, 1999
- Company
- 3M Pharmaceuticals
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Immune response modifier
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ALDARA | 02239505 | Marketed |
Medicinal ingredients
- IMIQUIMOD 50 MG per G